A detailed history of Catalyst Funds Management Pty LTD transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 29,590 shares of SENS stock, worth $14,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,590
Holding current value
$14,203
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.32 - $0.49 $9,468 - $14,499
29,590 New
29,590 $10.3 Million
Q1 2024

Dec 04, 2024

BUY
$0.5 - $0.73 $14,700 - $21,462
29,400 Added 99.36%
58,990 $31.3 Million

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $223M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.